CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: ,68 Analysis of the ligand-receptor interaction between neutrophil-7 and CD8 TE cells revealed that there were significant differences of ligand-receptor pairs such as NR3C1_FASLG and TNFSF14_TNFRSF14 between CML patients and healthy samples, among which NR3C1_FASLG stimulated the expansion of effector T cells and TNFRSF14 promoted cytotoxicity,69 which is consistent with our results.